Abstract A secondary analysis was conducted of a multicentre Australian cohort of 158 adults with type 1 diabetes using hybrid closed‐loop systems to examine the relationship between comorbidity burden and glycaemic outcomes. Comorbidities such as obesity, dyslipidaemia and anxiety/depression were highly prevalent, particularly in regional centres. Higher comorbidity burden was significantly associated with increased time below range (<3 mmol/L; r = 0.17, P = 0.013), but not with mean glucose or time in range. These findings highlight the influence of multimorbidity on glycaemic stability and underscore the need for individualised optimisation of automated insulin delivery therapy in real‐world settings.
Syed et al. (Mon,) studied this question.